Series A · Biotech · Ghent, Belgium · Founded 2018 · 11–50 employees
RheaVita is a Belgian biotech and pharmaceutical engineering company based in Ghent that develops and markets **continuous, controlled freeze-drying (lyophilisation) technology** for biopharmaceuticals, enabling faster, scalable and flexible freeze-drying of vaccines, gene therapies, ATMPs and biologics by integrating all process steps into a single continuous production line with patented control systems; founded in 2018 as a spin-out from Ghent University, it also offers feasibility studies, formulation development, CDMO services and training courses to accelerate product and process development.
No open roles listed right now.